NOBRXIOL
DEAD

Serial Number

98164969

Owner

Virpax Pharmaceuticals, Inc.

Attorney

Patrick J. Halloran

Filing Date

Sep 5, 2023

Add to watchlist:

No watchlists yet
View on USPTO

NOBRXIOL Trademark

Serial Number: 98164969

NOBRXIOL is a trademark filed by Virpax Pharmaceuticals, Inc. on September 5, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Owner Contact Info

Virpax Pharmaceuticals, Inc. (11 trademarks)

Ste. 225
Malvern, PA 19355

Entity Type: 03

Trademark Details

Filing Date

September 5, 2023

Registration Date

Not Registered

Published for Opposition

June 4, 2024

Goods & Services

Pharmaceutical substances for the treatment of epilepsy, convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus pharmaceutical preparations and substances for the treatment of pediatric epilepsy

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Oct 17, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Oct 17, 2025 ABN6
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 27, 2024 EXRA
SOU EXTENSION 1 GRANTED
Dec 27, 2024 EX1G
SOU EXTENSION 1 FILED
Dec 27, 2024 EXT1
SOU TEAS EXTENSION RECEIVED
Dec 27, 2024 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Jul 30, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jun 4, 2024 NPUB
PUBLISHED FOR OPPOSITION
Jun 4, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 15, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
May 1, 2024 CNSA
ASSIGNED TO EXAMINER
May 1, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2023 NWOS
NEW APPLICATION ENTERED
Sep 8, 2023 NWAP